The company said that the profits after taxes rose to $ 7 billion in the past year, up from $ 6 billion in 2023, noting a sharp increase in cancerous drug sales. Read more
The company said that the profits after taxes rose to $ 7 billion in the past year, up from $ 6 billion in 2023, noting a sharp increase in cancerous drug sales. Read more
